HTG Molecular Diagnostics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. HTG Molecular Diagnostics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 29% to $6,366,220. Profit margin reached -339%. Total operating expenses were $22,623,682.

Profit Margin

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM): Profit margin
2013 2.24M -11.76M -524.7%
2014 3.32M -13.95M -419.3%
2015 4.04M -21.39M -529.44%
2016 5.13M -26.03M -507.32%
2017 14.75M -18.96M -128.46%
2018 21.50M -16.45M -76.52%
2019 19.20M -19.29M -100.49%
2020 8.54M -20.87M -244.13%
2021 8.90M -17.14M -192.49%
2022 6.36M -21.59M -339.2%

HTGM Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
6.36M8.90M8.54M19.20M21.50M14.75M5.13M4.04M3.32M2.24M
Cost of revenue
4.57M4.09M3.99M8.91M5.09M4.97M4.13M3.33M3.20M2.24M
Gross profit
1.79M4.81M4.55M10.29M16.41M9.78M996.84K706.06K124.04K-3.82K
Operating exp.
Research and development
6.78M6.08M6.07M10.57M12.59M9.99M7.90M4.60M3.07M4.19M
Selling and marketing
0000000000
Total operating expenses
22.62M22.63M24.14M29.25M32.57M27.51M25.32M19.59M12.97M11.91M
Operating income
-20.82M-17.82M-19.58M-18.96M-16.15M-17.72M-24.33M-18.89M-12.84M-11.91M
Other income (expenses), net
-754.04K701.13K-1.27M-334.18K-291.16K-1.23M-1.69M-2.49M-1.10M146.04K
Income before tax
-21.58M-17.12M-20.85M-19.29M-16.45M-18.95M-26.02M-21.38M-13.95M-11.76M
Income tax expense
10.83K22.47K14.41K3.37K3.52K2.92K10.11K10.18K-402.68K357.91K
Net income
-21.59M-17.14M-20.87M-19.29M-16.45M-18.96M-26.03M-21.39M-13.95M-11.76M
Earnings per share
Basic EPS
-24.28-29.66-54.12-91.17-0.75-2.24-4.58-5.92-52.33-44.13
Diluted EPS
-24.28-29.66-54.12-91.17-0.75-2.24-4.58-5.92-5.95-44.13
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source